These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37268269)

  • 1. Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling.
    Tang Y; Yang P; Jin M; Huang S; Chen H; Chen L; Yang J; Su N
    Bone; 2023 Sep; 174():116817. PubMed ID: 37268269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
    McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
    J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant activation of Wnt signaling pathway altered osteocyte mineralization.
    Zhou Y; Lin J; Shao J; Zuo Q; Wang S; Wolff A; Nguyen DT; Rintoul L; Du Z; Gu Y; Peng YY; Ramshaw JAM; Long X; Xiao Y
    Bone; 2019 Oct; 127():324-333. PubMed ID: 31260814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.
    Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
    Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
    Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
    Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
    Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Function of Wnt Ligands on Osteocyte and Bone Remodeling.
    Du JH; Lin SX; Wu XL; Yang SM; Cao LY; Zheng A; Wu JN; Jiang XQ
    J Dent Res; 2019 Jul; 98(8):930-938. PubMed ID: 31282847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth.
    Chen S; Feng J; Bao Q; Li A; Zhang B; Shen Y; Zhao Y; Guo Q; Jing J; Lin S; Zong Z
    J Bone Miner Res; 2015 Jul; 30(7):1184-94. PubMed ID: 25639729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation.
    Kang KS; Hong JM; Robling AG
    Bone; 2016 Jul; 88():138-145. PubMed ID: 27143110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.
    Kondoh S; Inoue K; Igarashi K; Sugizaki H; Shirode-Fukuda Y; Inoue E; Yu T; Takeuchi JK; Kanno J; Bonewald LF; Imai Y
    Bone; 2014 Mar; 60():68-77. PubMed ID: 24333171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading.
    Javaheri B; Stern AR; Lara N; Dallas M; Zhao H; Liu Y; Bonewald LF; Johnson ML
    J Bone Miner Res; 2014 Mar; 29(3):705-15. PubMed ID: 23929793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
    Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF Receptor Deletion Amplifies Cortical Bone Dysfunction in Mice With STAT3 Hyperactivation in Osteocytes.
    Isojima T; Walker EC; Poulton IJ; McGregor NE; Wicks IP; Gooi JH; Martin TJ; Sims NA
    J Bone Miner Res; 2022 Oct; 37(10):1876-1890. PubMed ID: 35856245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.